How to resolve impurities and variants in oligo and protein therapeutics using MDi column technology

Tu, 17.11.2026 19:00 CET
How can impurities and variants in complex oligonucleotide and protein therapeutics be separated? Discover SurePac MDi column applications for nucleic acids, antibodies, and other therapeutic proteins.
Labroots: How to resolve impurities and variants in oligo and protein therapeutics using MDi column technology
Labroots: How to resolve impurities and variants in oligo and protein therapeutics using MDi column technology

The increasing diversity and complexity of therapeutic biomolecules places new demands on chromatographic separations. Oligonucleotides, monoclonal antibodies, antibody-drug conjugates, and other emerging modalities present different analytical challenges, yet all require efficient and reproducible separations to support confident characterization.

In this webinar, we will introduce monodisperse inert (MDi) column technology and discuss how the combination of precisely controlled polymeric particles and inert column hardware can support reversed-phase analysis across diverse biomolecular modalities. We will examine how particle morphology, pore architecture, and column hardware influence chromatographic performance, including separation efficiency, recovery, and robustness.

Application examples using Thermo Scientific™ SurePac™ MDi™ Columns will illustrate separations ranging from therapeutic oligonucleotides and nucleic acids to monoclonal antibodies and other therapeutic proteins. The webinar will also discuss practical considerations for selecting and applying these technologies across demanding biomolecule characterization workflows.

Learning Objectives:

  • Identify how monodisperse column technology can support high-resolution separations and characterization of complex biomolecules.
  • Describe how column chemistry, particle architecture, and operating conditions influence method robustness and applicability across different biomolecular modalities.
  • Discuss chromatographic factors that can reduce adsorption, carryover, repeat analyses, and method-development challenges in biomolecule HPLC.

Date & Time

  • Date: November 17, 2026
  • Time: 10:00 AM PT, 1:00 PM ET

Presenter: Mauro De Pra, PhD (Product Marketing Manager, Thermo Fisher Scientific)

Mauro De Pra, who has been with Thermo Fisher Scientific since 2010, has held roles spanning across product development, application development, technical support, and product marketing. His work focuses on HPLC and advanced separation technologies, supporting the development and commercialization of innovative LC solutions. Mauro has authored multiple peer-reviewed publications in the field of separation sciences and brings extensive experience translating analytical challenges into practical solutions for pharmaceutical and biopharmaceutical applications. Before joining Thermo Fisher Scientific, he worked as an Analytical Development Scientist in the Pharmaceutical industry. Mauro holds a Ph.D. in Chemistry from the University of Amsterdam.

Presenter: Sukhdev Bangar (Senior Product Marketing Manager, Thermo Fisher Scientific)

Sukhdev graduated from De Montfort University (UK) with a BSc. in Pharmaceutical Sciences. After which he worked in the Pharmaceutical industry at GSK, 3M & Astra Zeneca performing LC & LC-MS analyses.

From 2005 till 2023 Sukhdev worked various roles at Waters Corporation; LC-MS applications, Pharma LC-MS Demo group leader and HPLC Product manager.

In his current role at Thermo Fisher Scientific he is responsible for marketing activities for the Vanquish analytical LC’s product portfolio. In this role, he represents the voice of the customer helping shape the future of Vanquish LC systems.

labroots
LinkedIn Logo